The Fibrin Patch Soft Tissue Study
Completed · Phase 2
Conditions studied: Hemostasis
In brief
The effectiveness objective of this study is to evaluate whether Fibrin Patch is superior to SURGICEL™ as an adjunct to achieving hemostasis during surgical procedures involving soft tissue bleeding in abdominal, pelvic, retroperitoneal and (non-cardiac) thoracic surgery.
Key facts
- Study ID
- NCT00658723
- Run by
- Ethicon, Inc.
- People needed
- 141
- Starts
- 2008-03-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2014-09-11
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects >= 18 years of age, requiring non-emergent, open, abdominal, retroperitoneal, pelvic or thoracic (non-cardiac) surgical procedures
- Presence of an appropriate soft tissue Target Bleeding Site (TBS) as identified intraoperatively by the surgeon
- Subjects must be willing to participate in the study, and provide written informed consent
You may not qualify if…
- Subjects with any intra-operative findings identified by the surgeon that may preclude conduct of the study procedure
- Subject with TBS within an actively infected field
- Bleeding site is in, around, or in proximity to foramina in bone, or areas of bony confine
- Subjects with known intolerance to blood products or to one of the components of the study product
- Subjects unwilling to receive blood products
- Subjects with immunodeficiency diseases (including known HIV)
- Subjects who are known, current alcohol and / or drug abusers
- Subjects who have participated in another investigational drug or device research study within 30 days of enrollment
- Female subjects who are pregnant or nursing
Where it is running
- University of Alabama — Birmingham, Alabama, United States
- Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
- Baptist Hosptial — Miami, Florida, United States
- Emory University Hospital — Atlanta, Georgia, United States
- Medical College of Georgia — Augusta, Georgia, United States
- University of Maryland Medical Center — Baltimore, Maryland, United States
- St. Agnes Healthcare, Inc. — Baltimore, Maryland, United States
- Long Island Jewish Medical Center — New Hyde Park, New York, United States
- Lehigh Valley Hospital — Allentown, Pennsylvania, United States
- The University of Texas MD Anderson Cancer Center — Houston, Texas, United States
- Weill Medical Colleges of Cornell University - Methodist Hospital — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.